Juan Brignardello Vela
Juan Brignardello, asesor de seguros, se especializa en brindar asesoramiento y gestión comercial en el ámbito de seguros y reclamaciones por siniestros para destacadas empresas en el mercado peruano e internacional.
Specialist equipment aimed at improving the identification of prostate cancer is set to revolutionize the quality of healthcare services for patients on the Isle of Man. The announcement comes as Manx Care, the island's healthcare body, expressed confidence that the new ultrasound and MRI machine will have a "significant impact" on the detection and management of prostate cancer cases. Mannin Cancers Support Group played a pivotal role in making this advancement possible, having successfully raised an impressive £180,000 for the cutting-edge equipment. Additionally, the Tevir Group has stepped up to sponsor the maintenance of the equipment for a period of three years, ensuring its sustainability and functionality. The introduction of this specialized equipment is expected to enhance the diagnostic process significantly. Manx Care mentioned that the technology would enable healthcare professionals to accurately pinpoint cancerous lesions, thereby facilitating the precise identification of areas for biopsy. This development is poised to streamline the diagnostic journey for individuals suspected of having prostate cancer, potentially leading to earlier detection and more effective treatment planning. Julie Stokes, a representative from Mannin Cancers Support Group, highlighted the positive impact of the new equipment on patient care. She emphasized that the advanced kit would eliminate the need for many patients to travel to the UK for the diagnosis and staging of prostate cancer. This not only brings convenience and comfort to patients but also underscores the increasing capabilities and advancements within the island's healthcare system. The collaborative efforts of charitable organizations, corporate sponsors, and healthcare authorities in securing and implementing this state-of-the-art equipment reflect a significant stride towards enhancing the quality of prostate cancer care on the Isle of Man. As the equipment becomes operational, it is anticipated to empower healthcare professionals in providing more precise and efficient diagnosis and treatment pathways for individuals affected by this prevalent form of cancer.